Readmission for Newborn Jaundice: The Value of the Coombs' Test in Predicting the Need for Phototherapy

Clinical Pediatrics

Volumn 43, Issue 1, 2004, Pages 63-68

  Madan, Ashima ^a,b   Huntsinger, Kay ^b   Burgos, Anthony ^a,b   Benitz, William E ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EL CAMINO HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD GROUP O; COOMBS TEST; FOLLOW UP; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; NEWBORN; NEWBORN JAUNDICE; PHOTOTHERAPY; PHYSICIAN; PRACTICE GUIDELINE; RETROSPECTIVE STUDY; REVIEW; RISK FACTOR; UMBILICAL CORD BLOOD;

ABO BLOOD-GROUP SYSTEM; COOMBS' TEST; FEMALE; HUMANS; INFANT, NEWBORN; JAUNDICE, NEONATAL; MALE; NEONATAL SCREENING; PATIENT READMISSION; PHOTOTHERAPY; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; RH-HR BLOOD-GROUP SYSTEM; RISK FACTORS;

EID: 1642540120     PISSN: 00099228     EISSN: None     Source Type: Journal    
DOI: 10.1177/000992280404300108     Document Type: Review

References (28)

1. Bjure J, Liden G, Reinand T, et al. A follow-up study of hyperbilirubinemia in full-term infants without isoimmunization. Acta Pediatr. 1961;50:437-443.
2. Edmonson MB, Stoddard JJ, Owens LM. Hospital readmission with feeding-related problems after early postpartum discharge of normal newborns. JAMA. 1997;278:299-300.
3. Seidman DS, Stevenson DK, Ergaz Z, et al. Hospital readmission due to neonatal hyperbilirubinemia. Pediatrics. 1995;96:727-729.
4. McDonald MG. Hidden risks: early discharge and bilirubin toxicity due to glucose-6-phosphate dehydrogenase deficiency. Pediatrics. 1995;96:734-736.
5. Bhutani VK, Johnson L, Sivieri EM. Predictive ability of a predischarge hour-specific serum bililrubin for subsequent significant hyperbilirubinemia in healthy term and near-term newborns. Pediatrics. 1999;103:6-14.
6. Newman TB, Escobar GJ, Branch PT, et al. Incidence of extreme hyperbilirubinemia in a large HMO. Amb Child Health. 1997;3:203(Abstract).
7. Maisels MJ, Newman TB. Kernicterus in otherwise healthy, breastfed term newborns. Pediatrics. 1995;96:730-733.
8. Brown AK, Johnson L. Loss of concern about jaundice and the reemergence of kernicterus in full-term infants in the era of managed care. In: Fanaroff AA, Klaus MH, eds. The Year Book of Neonatal and Perinatal Medicine. St Louis, MO: Mosby-Year Book; 1996:17-28.
9. Stevenson DK, Vreman HJ, Oh W, et al. Bilirubin production in healthy term infants as measured by carbon monoxide in breath. Clin Chem. 1994;40:1934-1939.
10. Vreman HJ, Wong RJ, Harmatz P, et al. Validation of the Natus CO-Stat™ End Tidal Breath Analyzer in children and adults. J Clin Monit Comput. 1999;15:421-427.
11. Stevenson DK, Fanaroff AA, Maisels J, et al. Prediction of hyperbilirubinemia in near-term and term infants. Pediatrics. 2001;18. url:http;//www.jcaho.org/ptsafety-frm.html.
12. Joint Commission on Accreditation of Healthcare Organizations. Kernicterus threatens healthy newborns. Sentinel Event Alert 2001; issue 18 Kernicterus. JCAHO. 2001:18.
13. Brown AK, Damus K, Kim MH, et al. Factors relating to readmission of term and near-term neonates in the first two weeks of life. J Perinat Med. 1999;27:263-275.
14. Maisels MJ, Newman TB. Jaundice in full-term and near-term babies who leave the hospital within 36 hours. Clin Perinatol. 1998;25:295-302.
15. Braveman P. Problems associated with early discharge of newborn infants: a critical review of the literature. Pediatrics. 1995;96:716-726.
16. Gale R, Seidman DS, Dollberg S, Stevenson DK. Epidemiology of neonatal jaundice in the Jerusalem population. J Pediatr Gastroenterol Nutr. 1990;10:82-86.
17. Bratlid D. Bililrubin toxicity: pathophysiology and assessment of risk factors. N Y J Med. 1991;91:489-492.
18. http://www.redcross.org/services/biomed/blood/supply/usagefacts.html.
19. Kaplan E, Herz F, Scheye E. ABO hemolytic disease of the newborn without hyperbilirubinemia. Am J Hematol. 1976;1:279-282.
20. Procianoy RS, Giacomini CB, Farina DM, et al. Early diagnosis of ABO hemolytic disease of the newborn. Eur J Pediatr. 1987;146:390-393.
21. Schonitzer D, Frisch H. Incidence, laboratory diagnosis and serologic prediction of hemolytic disease of newborn infants due to ABO incompatibility. Pediatr Pathol. 1984;19:263-278.
22. Risemberg HM, Mazzi E, MacDonald MG, et al. Correlation of cord bilirubin levels in hyperbilirubinemia in ABO incompatibility. Arch Dis Child. 1977;52:219-222.
23. Serrao PA, Mofanlou HD. Significance of anti-A and anti-B isohemagglutinins in cord blood of ABO incompatible newborn infants: correlation with hyperbilirubinemia. J Perinatol. 1989;9:154-158.
24. Leistikow EA, Collin MF, Savastano GD, et al. Wasted health care dollars. Routine cord blood type and Coombs' testing. Arch Pediatr Adolesc Med. 1995;149:1147-1151.
25. Maisels MJ, Kring E. Length of stay, jaundice and hospital readmission. Pediatrics. 1998;101:995-998.
26. Beutler E, Gelbart T, Demina A. Racial variability in the UDP-glucuronsyltransferase 1 (UGT1A) promoter: a balanced polymorphism for regulation of bilirubin metabolism? Proc Natl Acad Sci USA. 1998;95:8170-8174.
27. Kaplan M, Hammerman C. Glucose-6-phosphate dehydrogenase-deficient neonates: a potential cause for concern in North America. Pediatrics. 2000;106:1478-1480.
28. Martinez JC, Garcia HO, Otheguy Le, et al. Control of severe hyperbilirubinemia in full-term newborns with the inhibitor of bilirubin production Sn-mesoporhyrin. Pediatrics. 1999;103:1-5.